A5070063160- Sepsis Diagnosis and Treatment
- Pneumonia and Respiratory Infections
- Emergency and Acute Care Studies
- Orthopedic Infections and Treatments
- Ion Transport and Channel Regulation
- Cardiac electrophysiology and arrhythmias
- Pneumocystis jirovecii pneumonia detection and treatment
- COVID-19 Clinical Research Studies
- Hematological disorders and diagnostics
- Nosocomial Infections in ICU
- Lung Cancer Treatments and Mutations
- Lymphoma Diagnosis and Treatment
- Hemodynamic Monitoring and Therapy
- Erythropoietin and Anemia Treatment
- Long-Term Effects of COVID-19
- Biomedical Ethics and Regulation
- CNS Lymphoma Diagnosis and Treatment
- Streptococcal Infections and Treatments
- Iron Metabolism and Disorders
- Nematode management and characterization studies
- Ion channel regulation and function
- Biosimilars and Bioanalytical Methods
- CAR-T cell therapy research
- Infectious Diseases and Tuberculosis
- Heart Failure Treatment and Management
Tel Aviv University
2021-2024
Rabin Medical Center
2021-2024
Istituti Clinici Scientifici Maugeri
2020
Interleukin-6 inhibitors showed promising results in observational trials of patients with coronavirus disease 2019 (COVID-19).To evaluate whether interleukin-6 inhibitor tocilizumab (TCZ) reduces mortality among hospitalized COVID-19 patients.A systematic review and meta-analysis.Systematic meta-analysis randomized controlled (RCTs) comparing TCZ vs. placebo/control, for treatment adults COVID-19. Primary outcome was 28-30 days all-cause mortality. Search conducted up to 1 April 2021. Two...
Sepsis is associated with excessive release of catecholamines, which causes tachycardia and correlated poor clinical outcome. β-Blockers (BBs) may blunt this effect on heart rate (HR). The objective study to assess whether long-term BB therapy better outcomes in patients sepsis admitted internal medicine wards.We performed a single-center, observational cohort study. We included adult who were hospitalized departments due sepsis. A propensity score model for was used match patients. primary...
<b><i>Background:</i></b> Tocilizumab has been proposed as an effective treatment for severe COVID-19. We aimed to investigate whether tocilizumab administration is associated with increased availability of serum iron which may possibly be adverse effects on clinical outcomes. <b><i>Methods:</i></b> performed observational, retrospective cohort study. included adults, who were hospitalized in ICU the diagnosis COVID-19 infection eligible...
Sepsis and pneumonia in the elderly comprise a significant portion of medical admissions. Chloramphenicol has been used Israel for treatment bacterial infections, without evidence regarding its efficacy safety.
Abstract Background Andersen-Tawil Syndrome type 1 (ATS1) in a rare arrhythmogenic disease caused by loss-of-function mutations the KCNJ2 gene and characterized ventricular arrhythmias, dysmorphic features episodes of periodic paralysis. Although prognosis ATS1 patients is typically considered benign, definitive outcome data are lacking. Purpose We aimed to: 1) define risk life-threatening arrhythmic events (LAEs); 2) identify factors for such events; 3) assess efficacy anti-arrhythmic drugs...